ARCHIVES

Abraxane and Gemcitabine Improves Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

On Capitol Hill: Funding Outlook Brighter For NIH and NCI as appropriators Provide Increases

October 1, 1999

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

June 3, 2005

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

December 31, 2010

UC Davis Study Finds Patients Need Practical Information

June 28, 2002

Sullivan Confirmation Hearing Set For Feb. 1

January 27, 1989

Scatter Radiation from Mammography Presents No Increased Cancer Risk

December 28, 2012